Equifax Inc. logo EFX - Equifax Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 24
HOLD 11
SELL 1
STRONG
SELL
0
| PRICE TARGET: $214.36 DETAILS
HIGH: $245.00
LOW: $182.00
MEDIAN: $212.00
CONSENSUS: $214.36
UPSIDE: 11.71%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong
Trading 140.5% above fair value
Current Price $191.89
Bear Case $63.84 66.7% downside ($63.84 - $191.89) / $191.89 = -66.7% $5.32 × 12x P/E
Fair Value $79.80 58.4% downside ($79.80 - $191.89) / $191.89 = -58.4% $5.32 × 15x P/E
Bull Case $95.76 50.1% downside ($95.76 - $191.89) / $191.89 = -50.1% $5.32 × 18x P/E

Adjust Assumptions

15.0x
5.32$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 36.1x

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $5.32, the base-case value is $79.80 per share. DDM cross-check: $216.19.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (36 analysts) $214.36
Analyst Range $182.00 – $245.00
Divergence from AlphaVal 63%

Warnings

Dividend-based valuation: $216.19 (above our primary estimate by 171%). Large gaps may signal the dividend doesn't reflect full earning power.
Wall Street's average price target is $214.36 (from 36 analysts). Our estimate is 63% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples